A neuroimmunologist, Dr. Veronica Cipriani is interested in the treatment of multiple sclerosis and other demyelinating neurologic diseases such as neuromyelitis optica and anti-MOG encephalomyelitis. She is particularly interested in the diagnosis and management of autoimmune encephalitis and paraneoplastic neurologic disorders. Other clinical interests include the treatment of transverse myelitis and neurologic complications of rheumatologic disease. She enjoys seeing patients in clinic and teaching medical students, residents and fellows.
The University of Chicago Medicine
IL
Fellowship
Northwestern University
IL
Residency
Northwestern University
IL
Internship
University of Miami
FL
M.D.
Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters.
Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters. Int J MS Care. 2024 Mar-Apr; 26(2):57-60.
PMID: 38482517
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study.
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study. Mult Scler Relat Disord. 2023 Jun; 74:104718.
PMID: 37086634
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective study.
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective study. Mult Scler Relat Disord. 2023 Mar; 71:104523.
PMID: 36773543
Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.
Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches. PLoS One. 2022; 17(9):e0274778.
PMID: 36137122
Narcolepsy type 1 comorbid with myasthenia gravis: possible immunological link.
Narcolepsy type 1 comorbid with myasthenia gravis: possible immunological link. J Clin Sleep Med. 2022 07 01; 18(7):1889-1890.
PMID: 35393935
Clinical Characteristics of Multiple Sclerosis in African-Americans.
Clinical Characteristics of Multiple Sclerosis in African-Americans. Curr Neurol Neurosci Rep. 2019 11 13; 19(11):87.
PMID: 31720861
Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol.
Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol. Mult Scler Relat Disord. 2019 Jan; 27:397-399.
PMID: 30508784
Effective treatment of CLIPPERS with long-term use of rituximab.
Effective treatment of CLIPPERS with long-term use of rituximab. Neurol Neuroimmunol Neuroinflamm. 2018 May; 5(3):e448.
PMID: 29511706